Diagnostic Industry | List of Frontiers open access articles

Perspective

Published on 24 Mar 2022

The COVID-19 Pandemic – A Diagnostic Industry Perspective

in Clinical and Diagnostic Microbiology and Immunology

Shubhagata Das
Sherry Dunbar

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.862440

5,532 views
5 citations

Perspective

Published on 13 Jul 2022

Taking the Path Into the Dark Woods – Initial Industry Impact of the COVID-19 Pandemic

in Clinical and Diagnostic Microbiology and Immunology

Adam Thornberg

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.841825

1,971 views

Original Research

Published on 29 Nov 2021

Definition of CRISPR Cas12a Trans-Cleavage Units to Facilitate CRISPR Diagnostics

in Evolutionary and Genomic Microbiology

Hailong Lv
Jian Wang
Jian Zhang
Yijian Chen
Lei Yin
Dian Jin
Dayong Gu
Huailong Zhao
Yong Xu
Jin Wang

Frontiers in Microbiology

doi 10.3389/fmicb.2021.766464

18,310 views
73 citations

Original Research

Published on 15 May 2020

Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential

in Analytical Chemistry

Pranav Tripathi
Manisha Sachan
Seema Nara

Frontiers in Chemistry

doi 10.3389/fchem.2020.00400

5,356 views
19 citations

Hypothesis and Theory

Published on 05 Jun 2020

Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS

in Viral Immunology

Walter Fierz
Brigitte Walz

Frontiers in Immunology

doi 10.3389/fimmu.2020.01120

37,677 views
65 citations

Original Research

Published on 19 Jan 2022

Interkit Reproducibility of the Indirect Immunofluorescence Assay on HEp-2 Cells Depends on the Immunofluorescence Reactivity Intensity and Pattern

in Cytokines and Soluble Mediators in Immunity

Mônica Jesus Silva
Alessandra Dellavance
Danielle Cristiane Baldo
Silvia Helena Rodrigues
Marcelle Grecco
Monica Simon Prado
Renan Agustinelli
Luís Eduardo Coelho Andrade

Frontiers in Immunology

doi 10.3389/fimmu.2021.798322

6,076 views
14 citations

Articles

The COVID-19 Pandemic – A Diagnostic Industry Perspective

Taking the Path Into the Dark Woods – Initial Industry Impact of the COVID-19 Pandemic

Definition of CRISPR Cas12a Trans-Cleavage Units to Facilitate CRISPR Diagnostics

Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential

Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS

Interkit Reproducibility of the Indirect Immunofluorescence Assay on HEp-2 Cells Depends on the Immunofluorescence Reactivity Intensity and Pattern